Functional deficiency in endogenous interleukin‐1 receptor antagonist in patients with febrile infection‐related epilepsy syndrome

OBJECTIVE: We recently reported successful treatment of a child with febrile infection‐related epilepsy syndrome (FIRES), a subtype of new onset refractory status epilepticus, with the recombinant interleukin‐1 (IL1) receptor antagonist (IL1RA) anakinra. On this basis, we tested whether endogenous I...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Neurol
Main Authors: Clarkson, Benjamin D. S., LaFrance‐Corey, Reghann G., Kahoud, Robert J., Farias‐Moeller, Raquel, Payne, Eric T., Howe, Charles L.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2019
Teme:
Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6450741/
https://ncbi.nlm.nih.gov/pubmed/30779222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25439
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki